MDCO - Medicines Company
Previous close
84.9
0 0%
Share volume: 0
Last Updated: Fri 03 Jan 2020 06:00:00 AM CET
Pharmaceuticals: Other:
0%
PREVIOUS CLOSE
CHG
CHG%
$84.90
0.00
0.00%
Summary score
55%
Profitability
53%
Dept financing
25%
Liquidity
34%
Performance
70%
Sector
Health Technology
Industry
Pharmaceuticals: Other
Long-term ratios 30-Sep-2015 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-82.7%
Return on assets
-6.39%
Return on sales
-592.81%
Return on invested capital
-39.78%
Total debt ratio
89.22%
Debt ratio change over timeo
-8.16%
Current Ratio
2.84%
Quick Ratio
2.6%
Cash Position Ratio
2.06%
Short-term ratios 30-Sep-2018 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
59.24%
Return on assets
-5.09%
Return on sales
0%
Return on invested capital
-20.57%
Total debt ratio
103.58%
Debt ratio change over timeo
-10.63%
Current Ratio
3.97%
Quick Ratio
4.55%
Cash Position Ratio
3.22%
Last quarter ratios 30-Sep-2019
The data are presented for the financials results of the last quarter.
Return on equity
124.28%
Return on assets
-6.93%
Return on sales
0%
Return on invested capital
-50.2%
Total debt ratio
106.64%
Debt ratio change over time
-10.07%
Current Ratio
0.77%
Quick Ratio
0%
Cash Position Ratio
0.63%
Performance ratios (change over 4 years) 30-Sep-2015 - 30-Sep-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
930.67%
Return on assets
-47.77%
Return on sales
3511.14%
Return on invested capital
295.22%
Total debt ratio
-815.92%
Debt ratio change over time
-8.16%
Current Ratio
-24.35%
Quick Ratio
-22.64%
Cash Position Ratio
-16.61%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | MDCO | MYOK | ARQL | PTLA |
---|---|---|---|---|
Return on equity | -82.7% | -5.44% | -26.35% | -903.99% |
Return on assets | -6.39% | -4.95% | -11.28% | -17.23% |
Return on sales | -592.81% | 0% | 0% | -952.03% |
Return on invested capital | -39.78% | -114.84% | 65.12% | -54.62% |
Profitability | 0% | 50% | 50% | 0% |
Total debt ratio | 89.22% | 15.38% | 36.77% | 57.3% |
Debt ratio change over time | -8.16% | -0.98% | -0.59% | -0.77% |
Dept financing | 25% | 4% | 35% | 16% |
Current Ratio | 3.97% | 14.79% | 8.64% | 4.86% |
Quick Ratio | 4.55% | 0% | 0% | 4.81% |
Cash Position Ratio | 3.22% | 11.85% | 3.18% | 2.72% |
Liquididy | 27% | 50% | 27% | 53% |
Short-term ratios | MDCO | MYOK | ARQL | PTLA |
---|---|---|---|---|
Return on equity | 59.24% | -5.63% | -9.46% | -2857.58% |
Return on assets | -5.09% | -5.77% | -7.46% | -16.26% |
Return on sales | 0% | 0% | 0% | -308.47% |
Return on invested capital | -20.57% | -95.26% | 51% | 250.44% |
Profitability | 75% | 0% | 5% | 25% |
Total debt ratio | 103.58% | 6.35% | 20.64% | 82% |
Debt ratio change over time | -10.63% | -1.07% | -0.73% | -0.72% |
Dept financing | 25% | 2% | 5% | 45% |
Current Ratio | 3.97% | 14.79% | 8.64% | 4.86% |
Quick Ratio | 4.55% | 0% | 0% | 4.81% |
Cash Position Ratio | 3.22% | 11.85% | 3.18% | 2.72% |
Liquididy | 37% | 50% | 21% | 39% |